RIGEL PHARMACEUTICALS, INC. Interest Expense on Debt
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Interest Expense on Debt of $800.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2026-08-04
- RIGEL PHARMACEUTICALS, INC. interest expense, debt for the quarter ending 2026-06-30 was $800.00K, a 57.89% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. interest expense, debt for the quarter ending 2026-03-31 was $1.40M, a 26.32% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. interest expense, debt for the quarter ending 2025-06-30 was $1.90M.
- RIGEL PHARMACEUTICALS, INC. interest expense, debt for the quarter ending 2025-03-31 was $1.90M.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month |
|---|---|---|
| 2026-06-30 | $800.00K 10-Q · filed 2026-08-04 | $2.20M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.40M 10-Q · filed 2026-05-05 | |
| 2025-06-30 | $1.90M 10-Q · filed 2026-08-04 | $3.70M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $1.90M 10-Q · filed 2026-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |